CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition. Nasser AM, Melamed L, Wetzel E, Chang CC, et al. Clin Cancer Res 2024 May 8. doi: 10.1158/1078-0432.CCR-24-0562.

Read + Share

Amedeo Smart

Independent Medical Education

Nasser AM, Melamed L, Wetzel E, Chang CC, et al. CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition. Clin Cancer Res 2024 May 8. doi: 10.1158/1078-0432.CCR-24-0562.
PMID: 38718141